Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orient Europharma CoROCO:4120 +0.91%60 Gross Margin % is 46.67% as of Dec. 2025, which is 0% above its 10-year median of 46.48. GuruFocus rates ROCO:4120 with a GF Score™ of 60/100 and a GF Value™ of NT$44.98 (Fairly Valued). The stock has 4 warning signs investors should review. Among 941 Drug Manufacturers companies, Orient Europharma Co ranks better than 50.48% on this metric.
The historical rank and industry rank for Orient Europharma Co's Gross Margin % or its related term are showing as below:
ROCO:4120'
s Gross Margin % Range Over the Past 10 Years
Min: 42.96 Med: 46.48 Max: 48.69
Current: 48.69
During the past 13 years, the highestGross Margin % of Orient Europharma Co was 48.69%. The lowest was 42.96%. And the median was 46.48%.
ROCO:4120's Gross Margin % is ranked better than 50.48% of 941
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs ROCO:4120: 48.69
Orient Europharma Co had a gross margin of 46.67% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Orient Europharma Co was 1.80% per year.
Orient Europharma Co (ROCO:4120) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Orient Europharma Co had a gross margin of 46.67% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Orient Europharma Co Gross Margin % Related Terms
Orient Europharma Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Orient Europharma Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Orient Europharma Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orient Europharma Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orient Europharma Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Orient Europharma Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Orient Europharma Co (ROCO:4120) has a Gross Margin % of 46.67% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Orient Europharma Co and its competitors. This is near median its historical median of 46.48. Over the past decade, Orient Europharma Co's Gross Margin % has ranged from 42.96 to 48.69. According to the industry distribution chart, Orient Europharma Co ranks #466 out of 941 companies in the Drug Manufacturers industry, placing it in the top 49.5%.
Is Orient Europharma Co's Gross Margin % too high?
Orient Europharma Co's current Gross Margin % of 46.67% is near median its 10-year median of 46.48. Over the past 10 years, this metric has ranged from a low of 42.96 to a high of 48.69. The Drug Manufacturers industry median Gross Margin % is 48.54. Orient Europharma Co's value of 46.67% is 3.9% below this industry median. Based on the distribution chart, Orient Europharma Co ranks #466 out of 941 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Orient Europharma Co has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Orient Europharma Co's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Orient Europharma Co ranks #466 out of 941 companies for Gross Margin %. This puts Orient Europharma Co in the upper half of its industry. The industry median Gross Margin % is 48.54. Orient Europharma Co's value of 46.67% is 3.9% below this benchmark. Historically, Orient Europharma Co's own Gross Margin % has ranged from 42.96 to 48.69 over the past decade. While the company's 10-year median is 46.48 vs. the industry median of 48.54, Orient Europharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orient Europharma Co's current Gross Margin % of 46.67% is 3.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Orient Europharma Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orient Europharma Co's current Gross Margin % is 46.67%, which is near median its own 10-year median of 46.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orient Europharma Co stock overvalued right now?
Based on GuruFocus' analysis, Orient Europharma Co (ROCO:4120) is currently considered Fairly Valued. The stock's GF Value™ is NT$44.98, compared to a current price of NT$44.40 — trading 1.3% below its estimated fair value. The current Gross Margin % is 46.67%, which is near median its 10-year median of 46.48 and 3.9% below the Drug Manufacturers industry median of 48.54. Orient Europharma Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Orient Europharma Co (ROCO:4120), the current Gross Margin % is 46.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orient Europharma Co (ROCO:4120) Overvalued in 2026?
Based on GuruFocus' analysis, Orient Europharma Co stock appears to be undervalued.
The current stock price of NT$44.40 is trading 1.3% below its estimated GF Value™ of NT$44.98.
GuruFocus considers Orient Europharma Co to be Fairly Valued.
Key valuation signals for ROCO:4120:
Gross Margin %: 46.67% (near median its 10-year median of 46.48)
GF Value™: NT$44.98 vs. price of NT$44.40 (1.3% below fair value)
Industry Position: 3.9% below the Drug Manufacturers median (#466 of 941)
No single metric tells the full story. See the ROCO:4120 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements. The company's segments include: Western Pharma BU which includes manufacture and sale of pharmaceutical and cosmetic products; and Nutricare BU includes sale of various nutrition supplements and consumable healthcare products. It derives maximum revenue from Western Pharma BU segment. Geographically, it operates in Taiwan, China, and Southeast Asia.
60GF Score
Get the complete analysis for ROCO:4120
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4120 has been successfully added to your 
